FDA Panel Concerned Dermal Fillers Could Impact Breast Cancer Screening

(MedPage Today) — The FDA’s outside experts on Wednesday weighed in on the potential risks of dermal fillers for the décolletage area, particularly in regards to possible interference with breast cancer screening and imaging, and how these…

Read the full article on medpagetoday.com